These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 35950647)

  • 1. Dynamics of the Immune Response in Hospitalized SARS-CoV-2-infected Cancer Patients.
    Aoki MN; Nardin JM; Huergo LF; Blanes L; Morales HMP; Fornazari B; Conzentino MS; Migliorini MEA; Zanette DL
    Cancer Invest; 2022 Oct; 40(9):750-759. PubMed ID: 35950647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection.
    Abu Shanap M; Sughayer M; Alsmadi O; Elzayat I; Al-Nuirat A; Tbakhi A; Sultan I
    Front Immunol; 2022; 13():919762. PubMed ID: 35990639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients.
    Pascale SP; Nuccorini R; Pierri T; Di Mare R; Fabio L; Lerose E; Merlino MA; Schiavo P; Amendola A; Brucoli G; Caputo MD; Chitarrelli I; Cimminiello M; Coluzzi S; Filardi NB; Matturro A; Vertone D; Poggiaspalla M; Malaspina F; Musuraca G; Coralluzzo G; Mannarella C; Musto C; Bellettieri AP; Martinelli G; Cerchione C; Pizzuti M
    Front Immunol; 2022; 13():892331. PubMed ID: 36003404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
    Tuaillon E; Bolloré K; Pisoni A; Debiesse S; Renault C; Marie S; Groc S; Niels C; Pansu N; Dupuy AM; Morquin D; Foulongne V; Bourdin A; Le Moing V; Van de Perre P
    J Infect; 2020 Aug; 81(2):e39-e45. PubMed ID: 32504735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2.
    Marra A; Generali D; Zagami P; Cervoni V; Gandini S; Venturini S; Morganti S; Passerini R; Orecchia R; Curigliano G
    Ann Oncol; 2021 Jan; 32(1):113-119. PubMed ID: 33098994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in hematology-oncology patients.
    Bird PW; Badhwar V; Kennedy B; Ladani S; Tang JW
    J Med Virol; 2021 Jul; 93(7):4585-4591. PubMed ID: 33595119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.
    Chen Y; Li P; Ding Y; Liu M; Liu L; Yi B; Wu T; Dong H; Lao X; Ding K; Wang H; Zhang D; Tan X; Wang Z; Xu G; Cao G
    J Infect Public Health; 2021 Jul; 14(7):845-851. PubMed ID: 34118734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
    Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
    Front Immunol; 2021; 12():664619. PubMed ID: 34305895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Seroconversion in Children and Adults With Mild COVID-19.
    Toh ZQ; Anderson J; Mazarakis N; Neeland M; Higgins RA; Rautenbacher K; Dohle K; Nguyen J; Overmars I; Donato C; Sarkar S; Clifford V; Daley A; Nicholson S; Mordant FL; Subbarao K; Burgner DP; Curtis N; Bines JE; McNab S; Steer AC; Mulholland K; Tosif S; Crawford NW; Pellicci DG; Do LAH; Licciardi PV
    JAMA Netw Open; 2022 Mar; 5(3):e221313. PubMed ID: 35262717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.
    Re D; Barrière J; Chamorey E; Delforge M; Gastaud L; Petit E; Chaminade A; Verrière B; Peyrade F
    Leuk Lymphoma; 2021 Dec; 62(13):3308-3310. PubMed ID: 34308748
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune response against SARS-CoV-2 in pediatric patients including young infants.
    Kawamura Y; Higashimoto Y; Miura H; Ihira M; Inaba M; Ito R; Kozawa K; Yoshikawa T
    J Med Virol; 2021 Mar; 93(3):1776-1779. PubMed ID: 32897544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SARS-CoV-2 antibodies kinetics in hospitalized patients].
    Zuanich C; Garcia Rosolen N; Olmos Vargas P; Arévalo D; Donati P; Balbaryski J
    Medicina (B Aires); 2022; 82(1):3-12. PubMed ID: 35037855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination.
    Janzic U; Bidovec-Stojkovic U; Mohorcic K; Mrak L; Dovnik NF; Ivanovic M; Ravnik M; Caks M; Skof E; Debeljak J; Korosec P; Rijavec M
    Future Oncol; 2022 Jul; 18(23):2537-2550. PubMed ID: 35678621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal profile of antibody response to SARS-CoV-2 in patients with COVID-19 in a setting from Sub-Saharan Africa: A prospective longitudinal study.
    Gebrecherkos T; Kiros YK; Challa F; Abdella S; Gebreegzabher A; Leta D; Desta A; Hailu A; Tasew G; Abdulkader M; Tessema M; Tollera G; Kifle T; Arefaine ZG; Schallig HH; Adams ER; Urban BC; de Wit TFR; Wolday D
    PLoS One; 2022; 17(3):e0263627. PubMed ID: 35320286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes of throat swabs RNA and serum antibodies for SARS-CoV-2 and their diagnostic performances in patients with COVID-19.
    Qiu X; Xiang Y; Sun J; Wang X; Chen G; Xu X; Liao S; Yang N; Li S; Yang G; Tang Y; Fan J; Xie W; Hu H; Li Y; Zheng F
    Emerg Microbes Infect; 2020 Dec; 9(1):1974-1983. PubMed ID: 32787527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students.
    Lee CC; Segaloff HE; Cole D; Rosenblum HG; Morgan CN; Somers T; Desamu-Thorpe R; Foster MA; Currie D; Ruff J; Payne D; Whyte TJ; Abedi GR; Bigouette JP; Kahrs J; Langolf K; Remington P; Sterkel A; Kelly P; Westergaard RP; Bateman AC; Hsu CH; Tate JE; Kirking HL
    BMC Infect Dis; 2022 Mar; 22(1):314. PubMed ID: 35361140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort.
    Davidson N; Evans J; Giammichele D; Powell H; Hobson P; Teis B; Glover H; Guppy-Coles KB; Robson J
    Pathology; 2020 Dec; 52(7):764-769. PubMed ID: 33070955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.